Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5

Bristol-Myers puts a blockbuster price on new cancer med Empliciti

#1
C C Offline
http://www.fiercepharma.com/story/bristo...2015-12-01

EXCERPT: After winning FDA approval Monday, the latest multiple myeloma treatment--Empliciti, from Bristol-Myers Squibb ($BMY) and AbbVie ($ABBV)--is about to hit the scene. And like its rivals in the field, it'll be pricey. The ongoing monthly cost of the new med, to be used in combination with Celgene's ($CELG) Revlimid and dexamethasone, is about $10,000, Bristol-Myers Squibb spokeswoman Audrey Abernathy told FiercePharma in an emailed statement. Along with a two-month induction period, that figure puts the first-year annual cost of the drug at about $142,000 in the U.S....
Reply
#2
elte Offline
It all has gotten beyond the ability of the average person to deal with. Medicare Part D and the ACA made matters worse instead of helping.
Reply


Possibly Related Threads…
Thread Author Replies Views Last Post
  Stop pushing statins? + Transplanted pig heart had virus + Candy coated med pills C C 0 68 May 7, 2022 05:16 PM
Last Post: C C
  Loss of sleep doubles driver crash risk + Global med spending: $1.5 trillion by 2021 C C 0 326 Dec 7, 2016 12:25 AM
Last Post: C C



Users browsing this thread: 1 Guest(s)